Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) trial

Journal of Rheumatology

Volumn 24, Issue 7, 1997, Pages 1295-1302

  Bluhm, Gilbert B ^a   Sharp, John T ^b   Tilley, Barbara C ^c   Alarcon, Graciela S ^d   Cooper, Sheldon M ^e   Pillemer, Stanley R ^f   Clegg, Daniel O ^g   Heyse, Stephen P ^h   Trentham, David E ⁱ   Neuner, Rosemarie ^j   Kaplan, David A ^k   Leisen, James C C ^a   Buckley, Lenore ^l   Duncan, Howard ^a   Tuttleman, Marilyn ^h   Li, Shuhui ^c   Fowler, Sarah E ^c  

^a HENRY FORD HOSPITAL   (United States)

^b Tifton Medical Clinic   (United States)

^c HENRY FORD HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF ALABAMA   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f Natl Inst Arthr Musculoskel S   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h Natl Institutes Allerg Infect D   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j O

^k STATE UNIVERSITY OF NEW YORK   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Joint radiographs; Minocycline; MIRA trial; Rheumatiod arthritis

Indexed keywords

MINOCYCLINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; ARTHROSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PLACEBOS; TREATMENT OUTCOME;

EID: 0030756923     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tilley BC, Alarcón GS, Heyse SP, et al, for the MIRA Trial Group: Minocycline in rheumatoid arthritis: Results of a 48-week double blinded placebo controlled trial. Ann Intern Med 1995; 122:81-9.
2. Empire Rheumatism Council Subcommittee: Empire Rheumatism Council multi center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years' treatment. Ann Rheum Dis 1957;16:277-88.
3. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH and Other Therapeutic Measures in Chronic Rheumatic Disease: A comparison of prednisolone with aspirin and other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173-86.
4. The Research Sub-Committee of the Empire Rheumatism Council: Gold therapy in rheumatoid arthritis. Final report of a multi center controlled trial. Ann Rheum Dis 1961;20:315-33.
5. Tugwell P, Boers M: OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: Conclusion. J Rheumatol 1993;20:590.
6. Felson DT, Anderson JJ, Boers M, et al: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
7. Sharp JT, Young DY, Bluhm GB, et al: How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
8. Shrout PE, Fleiss JL: Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979;86:420-48.
9. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR: Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med 1974;80:21-6.
10. Sharp JT: Radiological assessment of joint damage. The premier outcome measure in rheumatoid arthritis. In: Wolfe F, Pincus T, eds. Current Status and Future Potential in Rheumatoid Arthritis. New York: Dekker, 1994.
11. The Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973;16:353-8.
12. Borg G, Allander E, Lund B, et al: Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind, placebo controlled study. J Rheumatol 1988;15:1747-54.
13. Multicenter Trial Group: Controlled trial of D(-) penicillamine in severe rheumatoid arthritis. Lancet 1973;1:275-80.
14. The Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 1970;283:883-9.
15. Shiokawa Y, Hayrack Y, Honda M, Chagoma T, Acadia T, Asemia T: Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 1977;20:1464-72.
16. Papert A, Magyars KAE, Sharp J, Bier F: Chloroquine diphosphate in rheumatoid arthritis. A controlled trial. Ann Rheum Dis 1961;20:18-35.
17. Freedman A, Steinberg VL: Chloroquine in rheumatoid arthritis. A double blindfold trial of treatment for one year. Ann Rheum Dis 1960;19:243-50.
18. Gofton JP, O'Brien WM, Hurley JN, Scheffler BJ: Radiographic evaluation of erosion in rheumatoid arthritis. Double blind study of auranofin vs placebo. J Rheumatol 1984;11:768-71.
19. van Rijthoven AW, Dijkmans BA, Goei The HS, et al: Cyclosporin treatment for rheumatoid arthritis: A placebo controlled, double-blind, multicenter study. Ann Rheum Dis 1986;45:726-31.
20. van der Heijde DMFM, van Reil PL, Nuvar-Zwart IH, Gribnau FW, van de Putte LB: Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
21. Weinblatt ME, Polisson R, Blotner SD, et al: The effects of drug therapy on radiographic progression of rheumatoid arthritis: Results of a 36 week randomized trial comparing methotrexate to auranofin. Arthritis Rheum 1993;36:608-12.
22. Gibson T, Huskisson EC, Wojtulewski JA, et al: Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehabil 1976;15:211-5.
23. Hamdy H, McKendry RJR, Mierins E, Liver JA: Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four week controlled clinical trial. Arthritis Rheum 1987;30:361-8.
24. Halberg P, Bentzon MW, Crohn O, et al: Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Danish Med Bull 1984;31:403-9.
25. van Riel PCM, Larsen A, van de Putte LBA, Gribnau FWJ: Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clin Rheumatol 1986;5:359-64.
26. Berry H, Liyanage SP, Durance RA, Barnes CG, Berger A, Evans S: Azathioprine and penicillamine in treatment of rheumatoid arthritis: A controlled trial. BMJ 1976;1:1052-4.
27. Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Lemmens AM: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. Ann Intern Med 1991;114:999-1004.
28. Sharp JT, Lidsky MD, Duffy J, et al: Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response. Arthritis Rheum 1977;20:1179-87.
29. Scott DL, Greenwood A, Davies J, Maddison PJ, Maddison MC, Hall ND: Radiological progression in rheumatoid arthritis: Do D-penicillamine and hydroxychloroquine have different effects? Br J Rheumatol 1990;29:126-7.
30. López-Méndez A, Daniel WW, Reading JC, Ward JR, Alarcón GS: Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the Cooperative Systemic Studies of the Rheumatic Diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364-9.
31. Wilhelm FE, Kirby DS, Kraska AR, et al: Tenidap vs piroxicam plus hydroxychloroquine in rheumatoid arthritis. Results of a two-year trial (abstr). Arthritis Rheum 1994;(suppl)37:S336.
32. Alarcón GS, López-Méndez A, Walter J, et al: Radiographic evidence of disease progression in methotrexate treated and non-methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis. J Rheumatol 1992;19:1868-73.
33. Sharp JT, Wolfe F, Corbett M, et al: Radiologic progression in rheumatoid arthritis: How many patients are required in a therapeutic trial to test disease modification? Ann Rheum Dis 1993;52:332-7.